A breakthrough
in Alzheimer’s
treatment
Introducing Vguard: a non-invasive nighttime brain therapy
Vguard is a revolutionary therapy for Alzheimer’s disease and Mild Cognitive Impairment (MCI), designed to address memory loss and cognitive decline.
The treatment is based on a unique brain-focused neuromodulation technique known as vagus nerve stimulation, delivered non-invasively during sleep.
Our core innovation is a patented brain stimulation technology that works in synchrony with memory consolidation cycles during sleep
Vguard stimulates the auricular branch of the vagus nerve, below the sensory threshold, which has been shown to activate the hippocampus– the brain’s central hub for memory.
Early studies indicate meaningful improvements in cognitive performance and memory retention.
A brain therapy designed for Alzheimer’s patients
Alzheimer’s disease develops silently for more than a decade before the first noticeable symptoms appear.
This early stage, known as Mild Cognitive Impairment, marks the beginning of a neurodegenerative process that primarily affects the hippocampus, the brain’s memory center.
Vguard was created specifically to target these vulnerable memory regions.
Even more importantly, it works during sleep — the brain’s natural window for memory consolidation — enabling a deeper and more physiologically aligned therapeutic effect.
Brain therapy
Vguard is designed for chronic treatment, targeting the most devastating symptoms of Alzheimer’s — including memory loss and cognitive decline. It integrates seamlessly into daily life, helping individuals with early cognitive decline maintain or restore their mental abilities and preserve functional independence.
Neuroactive
Aiming to activate cerebral memory structures, using Auricular VNS
Non-invasive
Wearable, non-pharmacological, well-tolerated
Night
The brain therapy aligning with natural sleep cycles and memory consolidation periodsWhy it matters
Mild Cognitive Impairment and Alzheimer’s disease represent a rapidly escalating global healthcare crisis.
Key challenges
-
Lack of effective pharmacological treatment
Vguard offers a unique, non-pharmacological therapeutic approach, using non-invasive vagus nerve stimulation, proven to be safe and well-tolerated.
-
Unstoppable rise in Alzheimer’s cases
By 2050, global cases are expected to double, reaching 138 millions, placing immense pressure on families and healthcare systems.
-
A leading cause of mortality
Alzheimer’s disease is already the 5th leading cause of death worldwide.
Vguard - connected care
Vguard delivers a complete care ecosystem — combining breakthrough therapy with connected supports for patients, caregivers and clinicians.
Families and clinicians can monitor treatment through a dedicated smart mobile app, enabling safe supervision and ongoing optimization.
For families and caregivers
For communities & healthcare systems
For patients
Vguard Aiming to Regain Yourself
Create a brighter tomorrow for you and your family.
Proprietary Electrical activation
Patented electrode-skin interface providing safety, convenience and comfort